Randomized phase I trial of adjuvant individualized TG4050 vaccine in patients with locally advanced resected HPV-negative head and neck squamous cell carcinoma (HNSCC)C. Le Tourneau, et al.SITC 2024 Abstract available on the SITC website – Download the abstract and the poster